Development of a novel method for synthesis of a polymeric ultrasound contrast agent

被引:120
作者
El-Sherif, DM [1 ]
Wheatley, MA [1 ]
机构
[1] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA
关键词
ultrasound contrast agent; hollow polymer capsules; biodegradable polymer; PLGA (poly (lactic-co-glycolic acid)); acoustic enhancement;
D O I
10.1002/jbm.a.10586
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Medical ultrasound is a highly valuable diagnostic tool, especially when compared with other imaging modalities. It is a noninvasive, real-time, portable, extremely safe method compared with X-ray and inexpensive relative to magnetic resonance imaging. However, ultrasound is limited in its ability to distinguish between diseased and normal tissue. This limitation has led to the development of contrast agents. We have produced novel poly (lactic-co-glycolic) acid air-filled microcapsules that work well as ultrasound contrast agents, giving up to 24 and 25 dB enhancement when insonated in the medical imaging range at 5 and 7.5 MHz, respectively. The capsules were fabricated by modifying a double emulsion method to encapsulate camphor in the oil phase and ammonium carbonate in the aqueous phase, and later sublime the encapsulated material, leaving voids capable of being filled with a gas in their place. The role of the surfactant, poly vinyl alcohol, solution temperature, was studied and found to play an important role in the morphology of the capsules, altering their acoustic response. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:347 / 355
页数:9
相关论文
共 29 条
[1]
BERG K, 2001, ANAL VIEW BIG PHARM
[2]
Science, medicine, and the future - Microbubble contrast agents: a new era in ultrasound [J].
Blomley, MJK ;
Cooke, JC ;
Unger, EC ;
Monaghan, MJ ;
Cosgrove, DO .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7296) :1222-1225
[3]
Bokor D, 2000, AM J CARDIOL, V86, p19G
[4]
BOMMER WJ, 1984, J AM COLL CARDIOL, V3, P6, DOI 10.1016/S0735-1097(84)80423-4
[5]
BROPHY RM, 1990, ENCY PHARM TECHNOLOG, V2, P1
[6]
In vitro evaluation of acoustic properties of ultrasound contrast agents: Experimental set-up and signal processing [J].
Cachard, C ;
Bouakkaz, A ;
Gimenez, G .
ULTRASONICS, 1996, 34 (2-5) :595-598
[7]
Contrast echocardiography: Review and future directions [J].
Cheng, SC ;
Dy, TC ;
Feinstein, SB .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (12A) :41G-48G
[8]
IDENTIFICATION OF ULTRASOUND ECHOES FROM LEFT VENTRICLE BY USE OF INTRACARDIAC INJECTIONS OF INDOCYANINE GREEN [J].
FEIGENBA.H ;
STONE, JM ;
LEE, DA ;
NASSER, WK ;
CHANG, S .
CIRCULATION, 1970, 41 (04) :615-&
[9]
TWO-DIMENSIONAL CONTRAST ECHOCARDIOGRAPHY .1. INVITRO DEVELOPMENT AND QUANTITATIVE-ANALYSIS OF ECHO CONTRAST AGENTS [J].
FEINSTEIN, SB ;
TENCATE, FJ ;
ZWEHL, W ;
ONG, K ;
MAURER, G ;
TEI, C ;
SHAH, PM ;
MEERBAUM, S ;
CORDAY, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (01) :14-20
[10]
Quantitative acoustic characterization of a new surfactant-based ultrasound contrast agent [J].
Forsberg, F ;
Wu, YQ ;
Makin, IRS ;
Wang, WH ;
Wheatley, MA .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1997, 23 (08) :1201-1208